NLRP3 and atherosclerosis: More recently, a contribution of NLRP3 has been shown for a wider range of inflammatory and autoimmune diseases, including atherosclerosis (Duewell et al., 2010; Rajamäki et al., 2010) and myocardial infarction (Toldo and Abbate, 2018), while vitiligo associates with NLRP1 mutations (Jin et al., 2007; Grandemange et al., 2017).